Everbridge Teams with Blue Trident to Target $250,000 Donation in Support of CDC Foundation's Fight Against COVID-19 Pandemic
The CDC Foundation, Blue Trident (News - Alert), and Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced a charitable collaboration beginning with support of the CDC Foundation's response to the COVID-19 pandemic. The CDC Foundation, which is an independent nonprofit, helps the Centers for Disease Control and Prevention do more, faster by forging partnerships between CDC and others to fight threats to health and safety. Similarly, Everbridge's mission to keep people safe and organizations running calls for immediate and urgent focus in mitigating the threats from the COVID-19 pandemic to people, operations, and supply chains. Together, the CDC Foundation and Everbridge will collaborate in a number of ways with an initial focus on raising awareness about, and financial support for, the CDC Foundation's new campaign "All of Us: Combat Coronavirus." Leading off the financial contributions is Blue Trident, a 501(c)(3) charitable foundation led by Jaime (Everbridge Executive Chairman) and Pamela Ellertson. Blue Trident will match Everbridge employee contributions on a dollar-for-dollar basis up to $100,000 building on an Everbridge gift of $50,000 for a combined total target of $250,000.
Contributions to the "All of Us: Combat Coronavirus" campaign will:
For others wanting to contribute to the CDC Foundation, please visit the Everbridge Team giving page at https://give.cdcfoundation.org/Everbridge.
"The CDC Foundation saves and improves lives by unleashing the power of collaboration," said Jaime Ellertson of the Blue Trident Foundation. "We hope others will join in contributing to this worthy cause to support our courageous healthcare first responders combating the threat of this global pandemic."
"When we all work together, we believe that people and organizations can have a greater impact to address health challenges, domestically and globally, both in emergencies and under more normal conditions," said Judy Monroe, MD, president and CEO of the CDC Foundation. "Partners like Everbridge, along with the donations of Blue Trident, will provide speed and flexibility to support critical research and meet needs including personal protective equipment (PPE) for healthcare providers."
As the leader in Critical Event Management and Public Warning solutions, Everbridge supports over 3,700 first responder organizations, municipalities, counties and cities; 1,500 healthcare entities; over 5,000 enterprises; statewide systems of some of the most populous states in the U.S. including California, New York and Florida; as well as countrywide public warning systems for several countries including Australia, Greece, Iceland, the Netherlands, New Zealand, Peru, Singapore, and Sweden.
"Staying ahead of the coronavirus threat continues to be a major challenge for governments, businesses and healthcare systems across the globe," said David Meredith, CEO of Everbridge. "Our mission to keep people safe and organizations running aligns with the important work of the CDC Foundation to forge partnerships to fight threats to our health and safety. Together we can all make a difference to help strengthen the public health response to this crisis."
The Everbridge platform reaches over 550 million people across the world to protect against critical events such as global pandemics. In response to COVID-19, the Everbridge platform has already delivered over 100 million communications specific to coronavirus as well as launched COVID-19 Shield rapid deployment templates to protect people and maintain operations amid the pandemic.
To discuss giving opportunities, including an in-kind donation or forming a crowdfunding team through this campaign, contact Advancement at the CDC Foundation: by email at firstname.lastname@example.org or 404-523-1873.
About The CDC Foundation
About Blue Trident Foundation
All Everbridge products are trademarks of Everbridge, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.